[[{"@type":["BlogPosting"],"@id":"https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/#BlogPosting","@context":{"@vocab":"http:\/\/schema.org\/","kg":"http:\/\/g.co\/kg"},"url":["https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/","https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/"],"publisher":[{"@id":"https:\/\/www.regionalcancercare.org\/"}],"author":[{"@type":"Organization","@id":"https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/#BlogPosting_author_Organization","name":"Regional Cancer Care Associates"}],"inLanguage":"en-US","image":[{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/#BlogPosting_image_ImageObject","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-Preparing-Immunotherapy-Treatments.jpg"}],"headline":"Cancer Immunotherapy: Past, Present, and Future","dateModified":"2021-11-11T12:07:23+00:00","datePublished":"2020-01-25T17:07:52+00:00","description":"Cancer immunotherapy\u2019s history is long, involving dozens of researchers and spanning over 100 years. To learn more, visit the Regional Cancer Care Associates blog today.","articleBody":"\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tJanuary 25, 2020\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\nBy boosting the body\u2019s natural defenses, immunotherapy has helped countless people in their fight against cancer since the late 1800s. There are several different types of immunotherapy, including T cell therapy, monoclonal antibodies, cancer vaccines, and more.\nBut how did this powerful form of cancer treatment originate? Regional Cancer Care Associates breaks down cancer immunotherapy\u2019s history and how this modality has transformed into the life-changing medicine it is today.\nThe Dawning of Immunotherapy\nThe first use of immunotherapy can be traced as far back as the late 1800s. At that time, German physicians W. Busch and Friedrich Fehleisen injected Streptococcus bacteria into several patients\u2019 tumors, and this act led to complete remission for several types of cancers. This finding was confirmed in 1909 by an American surgeon, William B. Coley, MD, who helped spark a long line of immunotherapy research that is still ongoing.\nAt around the same time, German researcher Paul Ehrlich developed the side chain (receptor) theory, which laid the groundwork for our modern knowledge about drug-specific receptors. Thanks to each of these pioneering researchers, immunotherapy has developed into a promising mode of cancer treatment.\nImmunosurveillance\nOne of the biggest breakthroughs for cancer immunotherapy occurred in 1957, when Lewis Thomas and Frank M. Burnet proposed their theory of cancer immunosurveillance. Essentially, they suggested that lymphocytes, or white blood cells in the immune system, act as watchdogs that identify and destroy mutated cells in our bodies. One implication of their work was that these lymphocytes could be manipulated to destroy harmful cancer cells.\nToday, Thomas and Burnet\u2019s theory has been refined into what is known as cancer immunoediting. This complex process involves three major phases, including:\nElimination: when early tumor cells are destroyed by the immune systemEquilibrium: the modification, or equilibrium, of existing tumor cells by the immune systemEscape: when tumors avoid the immune system\u2019s recognition by using their own cells for growth, invasion, and more\nMonoclonal Antibodies\nAs mentioned, many different immunotherapies are available. One of these, monoclonal antibodies, involve the use of artificial antibodies that can help your body fight off infection. They were first discovered in 1975 by researchers C\u00e9sar Milstein & Georges K\u00f6hler, who went on to win the Nobel Prize in physiology in 1984 for their significant contributions to the field of science. In essence, physicians can attach monoclonal antibodies to select proteins on cancer cells, which helps your immune system target and eliminate them.\nModern Cancer Immunotherapy\nCurrently, researchers are pursuing modalities such as checkpoint inhibitors and adoptive T cell therapy, both of which have considerable promise for the future of cancer immunotherapy. These and other forms of immunotherapy are being developed in clinical trials, which deepen our knowledge of how medications and procedures can target specific types of cancer. As time progresses, more clinical trials are producing findings that improve our understanding of cancer and how to beat it.\nAs new ground continues to be broken in cancer research, oncologists are finding new ways of using immunotherapy to treat cancer. By learning more about the history of cancer immunotherapy, you can become more informed during your discussions with your doctor and your independent cancer research. To find out more, call or visit a Regional Cancer Care Associates location near you.\nwe are here for you\nFor more information or to schedule an appointment, call (844) 301-4158. You can also schedule an appointment by calling the RCCA location nearest you.\nRELATED ARTICLES\nRegional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.\n\u00a9 2022 Regional Cancer Care Associates. All rights reserved.","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/"},{"@context":"http:\/\/schema.org","@type":"LocalBusiness","address":{"@type":"PostalAddress","streetAddress":"Corporate Office 25 Main Street, Suite 601","postalCode":"07601","addressRegion":"NJ","addressLocality":"Hackensack","addressCountry":"USA","name":"Postal Address","@id":"https:\/\/www.regionalcancercare.org\/#PostalAddress"},"logo":{"@type":"ImageObject","width":"1024","height":"468","url":"https:\/\/www.regionalcancercare.org\/wp-content\/themes\/rccah\/dist\/images\/RCCA_logo.jpg","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/themes\/rccah\/dist\/images\/RCCA_logo.jpg"},"image":{"@id":"https:\/\/www.regionalcancercare.org\/wp-content\/themes\/rccah\/dist\/images\/RCCA_logo.jpg"},"contactPoint":[{"@type":"ContactPoint","contactOption":"https:\/\/www.regionalcancercare.org\/contact\/#ContactPointOption","availableLanguage":"https:\/\/en.wikipedia.org\/wiki\/English_language","areaServed":["https:\/\/en.wikipedia.org\/wiki\/New_Jersey","https:\/\/en.wikipedia.org\/wiki\/Hackensack,_New_Jersey"],"contactType":"customer support","telephone":"+1 (844) 346-7222","email":"info@regionalcancercare.org","description":"Corporate Office Regional Cancer Care Associates 25 Main Street, Suite 601 Hackensack, NJ 07601 info@regionalcancercare.org Phone: (844) 346-7222","name":"Contact Corporate Office","image":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2017\/06\/RCCA_logo-300x137.jpg","url":"https:\/\/www.regionalcancercare.org\/contact\/","@id":"https:\/\/www.regionalcancercare.org\/contact\/#CorporateOffice"},{"@type":"ContactPoint","contactOption":"https:\/\/www.regionalcancercare.org\/contact\/#ContactPointOption","availableLanguage":"https:\/\/en.wikipedia.org\/wiki\/English_language","areaServed":["https:\/\/en.wikipedia.org\/wiki\/New_Jersey","https:\/\/en.wikipedia.org\/wiki\/Hackensack,_New_Jersey"],"contactType":"customer support","telephone":"+1 (201) 510-0922","email":"msalvemini@regionalcancercare.org","description":"Media Inquiries: Mary Lou Salvemini Regional Cancer Care Associates Phone: (201) 510-0922 Email: msalvemini@regionalcancercare.org","name":"Contact Media Inquiries","image":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2017\/06\/RCCA_logo-300x137.jpg","url":"https:\/\/www.regionalcancercare.org\/contact\/","@id":"https:\/\/www.regionalcancercare.org\/contact\/#MediaInquiries"}],"areaServed":["https:\/\/en.wikipedia.org\/wiki\/Hackensack,_New_Jersey","https:\/\/en.wikipedia.org\/wiki\/New_Jersey"],"additionalType":"https:\/\/en.wikipedia.org\/wiki\/Treatment_of_cancer","alternateName":"RCCA","description":"Leaders in Advanced Compassionate Cancer Care. Fight cancer with leading-edge treatments, experienced skill and local caring\/convenience from one of the nation's largest networks of cancer specialists.","email":"info@regionalcancercare.org","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/","url":"https:\/\/www.regionalcancercare.org\/","sameAs":["https:\/\/twitter.com\/rgnlcancercare","https:\/\/www.facebook.com\/regionalcancercareassoc","https:\/\/www.linkedin.com\/company\/10059183","https:\/\/www.youtube.com\/channel\/UCFlVzU4UvZcyXBCe9ZSvAUQ"],"telephone":"+1 (844) 346-7222","name":"Regional Cancer Care Associates","@id":"https:\/\/www.regionalcancercare.org\/"}],{"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/www.regionalcancercare.org\/news\/#breadcrumbitem"},{"@type":"ListItem","position":2,"name":"Cancer Immunotherapy: Past, Present, and Future","item":"https:\/\/www.regionalcancercare.org\/news\/a-summarized-history-of-cancer-immunotherapy\/#breadcrumbitem"}]}]